INS and breast cancer: We first examined potential circadian dynamics and their disruption by LAN in a number of host factors including plasma levels of melatonin, total FAs (TFAs), LA, glucose, lactate and insulin in rats bearing tissue-isolated, steroid receptor negative (SR−) MCF-7 human breast cancer xenografts on an light/dark (LD) 12∶12 cycle [12].